Menu
Search
Home > Courses > Strategies (and New Agents) for Antiretroviral Therapy of HIV-1 Disease

Strategies (and New Agents) for Antiretroviral Therapy of HIV-1 Disease

Strategies (and New Agents) for Antiretroviral Therapy of HIV-1 Disease
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 3/27/2012
Review Date: 7/20/2012
Presenter
  • Roy M. Gulick, MD, MPH
    Rochelle Belfer Professor in Medicine, Chief, Division of Infectious Diseases, Weill Cornell Medicine
    Weill Medical College of Cornell University, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand the evolving recommendations for when to start antiretroviral therapy (ART) for HIV disease.
  2. Identify optimal initial ART regimens.
  3. Know strategies for treatment-experienced patients.
  4. Learn about new antiretroviral agents for the treatment of HIV disease.
Presenter Bio
Roy Gulick, MD, MPH
Roy M. Gulick, MD, MPH is the Rochelle Belfer Professor of Medicine and Chief of the Division of Infectious Diseases in the Department of Medicine at Weill Cornell Medicine/New York-Presbyterian Hospital. He is Principal Investigator of the NIH-funded Weill Cornell-New Jersey Medical School HIV Clinical Trials Unit and serves as the Co-Chair of the US DHHS Antiretroviral Treatment Guidelines Panel. He is an internationally-recognized leader in clinical research in HIV.
PRN Learning Modules